Prostate cancer was found in a smaller proportion of patients, 0.86% (1/116), where no variant was identified in one patient; along with skin, renal, and appendix cancer in 0.86% (1/116) of patients, where a variant in an MMR gene was identified in all three cases. Here, MRC1 is linked to appendix cancer.